Home Page

Transactions in relation to share buyback program

Read more ››

By: Nasdaq / GlobenewsWire - 25 Jun 2019

Forbes ranks LHC Group among “America’s Best-in-State” employers for 2019

Read more ››

By: Nasdaq / GlobenewsWire - 25 Jun 2019

Related companies:  LHC Group, Inc.

Kane Biotech Secures Large Order from Leading Quebec Retailer

Read more ››

By: Nasdaq / GlobenewsWire - 25 Jun 2019

Related companies:  Kane Biotech Inc.

Arvinas Receives Authorization to Proceed for ARV-471, a PROTAC® Protein Degrader to Treat Patients with Locally Advanced or Metastatic ER+ / HER2- Breast Cancer

Read more ››

By: Nasdaq / GlobenewsWire - 25 Jun 2019

Related companies:  Arvinas Inc.

AGTC Announces New Leadership Appointments

Read more ››

By: Nasdaq / GlobenewsWire - 25 Jun 2019

Related companies:  Applied Genetic Technologies Corp. (AGTC)

Anavex Life Sciences Announces First Patient Dosed in Extension Study to its U.S. Phase 2 Clinical Trial of ANAVEX®2-73 in Patients for Rett Syndrome

Read more ››

By: Nasdaq / GlobenewsWire - 25 Jun 2019

Related companies:  Anavex Life Sciences Corp.

Myriad Announces Publication of First Comprehensive Economic Study Demonstrating Cost Effectiveness of EndoPredict® for Breast Cancer

Read more ››

By: Nasdaq / GlobenewsWire - 25 Jun 2019

Related companies:  Myriad Genetics, Inc.

Harrow Health Adds Two Senior Executives to its Nashville Team

Read more ››

By: Nasdaq / GlobenewsWire - 25 Jun 2019

Related companies:  Harrow Health, Inc.

Akorn Receives FDA Warning Letter

Read more ››

By: Nasdaq / GlobenewsWire - 25 Jun 2019

Related companies:  Akorn, Inc.

Tauriga Sciences Inc. Presentation Today at 3:30-4:00pm EST at The MJ Micro Conference in Midtown Manhattan

Read more ››

By: Nasdaq / GlobenewsWire - 25 Jun 2019

Samuel E. Navarro Appointed to BioSig Board of Directors

Read more ››

By: Nasdaq / GlobenewsWire - 25 Jun 2019

Related companies:  BioSig Technologies, Inc.

Rafael Pharmaceuticals Enters into Out-Licensing Agreement with Ono Pharmaceutical to Accelerate Clinical Development and Commercialization of Cancer Drug Candidate CPI-613® (devimistat) in Japan and Other Asian Countries

Read more ››

By: Nasdaq / GlobenewsWire - 25 Jun 2019

Progressive Care Inc. Announces Steady Sales Growth in May

Read more ››

By: Nasdaq / GlobenewsWire - 25 Jun 2019

Predictive Technology Group Announces the Presentation of New Data Demonstrating the Genetic Basis of Endometriosis at ESHRE

Read more ››

By: Nasdaq / GlobenewsWire - 25 Jun 2019

Related companies:  Predictive Technology Group

Dova Pharmaceuticals Announces European Union Marketing Authorization for DOPTELET® (avatrombopag) for the Treatment of Thrombocytopenia in Patients with Chronic Liver Disease

Read more ››

By: Nasdaq / GlobenewsWire - 25 Jun 2019

Related companies:  Dova Pharmaceuticals, Inc.

Immutep Completes Patient Enrolment of the AIPAC Phase IIb Clinical Trial in Metastatic Breast Cancer

Read more ››

By: Nasdaq / GlobenewsWire - 25 Jun 2019

Auxly Announces Appointment of Andrew MacMillan as VP, Commercial Business Development

Read more ››

By: Nasdaq / GlobenewsWire - 25 Jun 2019

VPR Brands Provides Update on International Sales Progress

Read more ››

By: Nasdaq / GlobenewsWire - 25 Jun 2019

Medexus Appoints Accomplished Global Pharmaceutical Industry Executive Adele M. Gulfo to its Board of Directors

Read more ››

By: Nasdaq / GlobenewsWire - 25 Jun 2019

Cambrex Appoints Dottie Donnelly-Brienza as Senior Vice President and Chief Human Resources Officer

Read more ››

By: Nasdaq / GlobenewsWire - 25 Jun 2019

Related companies:  Cambrex Corporation

«  1  2  3  4  5  6  7 8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »